Author | Fred Saad, MD, FRCS | OncLive

Author | Fred Saad, MD, FRCS

Articles

Dr. Saad on Unique Characteristics of Apalutamide in M0CRPC

June 26, 2020

Video

Fred Saad, MD, FRCS, discusses unique characteristics of apalutamide compared with other antiandrogen agents in nonmetastatic castration-resistant prostate cancer.

Dr. Saad on the SPARTAN Trial in M0CRPC

June 10, 2020

Video

Fred Saad, MD, FRCS, discusses the randomized phase 3 SPARTAN trial in nonmetastatic castration-resistant prostate cancer.

x